RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

In a report released on January 17, Jon Arfstrom from RBC Capital maintained a Buy rating on Webster Financial (WBS – Research Report), with a ...

Morgan Stanley analyst Robert Koh maintained a Buy rating on AGL Energy Limited (AGLNF – Research Report) today and set a price target of ...

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

“We think Morgan Stanley benefits from favorable secular trends in the capital markets, wealth management, and investment banking,” he said in a research note. Morgan Stanley’s revenue from ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...

Research analysts at BMO Capital Markets began coverage on shares of Toast (NYSE:TOST – Get Free Report) in a report released ...